Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




READERS COMMENTS:

Medical Uses for Marijuana No Longer in the Weeds
Back to Item

New crop of companies are adding to the political debate and also providing clinical evidence.

2 Readers' Comments

Post a Comment

Posted by: Jobeth E

03/30/2011

<!--
@page { margin: 0.79in }
P { margin-bottom: 0.08in }
-->


We have different views on this issue. A number of
groups in U.S. have been campaigning to make it legal for some
reason. In the U.S., medical cannabis is kind of legal. 15 states
have legalized the narcotic, however it's still federally illegal.
Here is the proof: Investors
considering medical marijuana IPOs. The business of
supplying medical marijuana shops, and all associated products, could
be very profitable. By offering public stock, 2 relatively small
corporations in the United States are hoping to get even bigger.
These stock offerings will likely raise millions of dollars.

Posted by: Jon Quinn

06/16/2010

Awesome article, this debate has been happening now for many years despite the fact that medical marijuana has long been used to treat numerous diseases such as glaucoma or anxiety.  The issue that political figures have is the abuse that can occur with patients making up issues to get their medical marijuana cards.  Continuing research could also open numerous jobs in the biotech field as well as ongoing jobs for farming and agriculture.

Click here to log in or to register for free.

You will be taken back to your selected item after log-in/registration.

Subscription center

BACK TO TOP

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll
« More »     « View Results »     « Poll Archive »